VIRI

Virios Therapeutics, Inc.

0.33 USD
+0.00 (+1.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Virios Therapeutics, Inc. stock is down -22.56% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 February’s closed higher than January.

About Virios Therapeutics, Inc.

Virios Therapeutics, Inc. focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.